These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2695437

  • 1. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
    Trübestein G, Trübestein R, Ludwig M.
    Fortschr Med; 1989 Dec 20; 107(36):781-4. PubMed ID: 2695437
    [Abstract] [Full Text] [Related]

  • 2. Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of Angiology.
    Heidrich H, Allenberg J, Cachovan M, Creutzig A, Diehm C, Gruss J, Kriessmann A, Rieger H, Rudofsky G, Trampisch HJ.
    Vasa; 1992 Dec 20; 21(4):333-43. PubMed ID: 1485465
    [No Abstract] [Full Text] [Related]

  • 3. [Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].
    Branchereau A, Rouffy J.
    J Mal Vasc; 1995 Dec 20; 20(1):21-7. PubMed ID: 7745355
    [Abstract] [Full Text] [Related]

  • 4. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V, Mammarella A, Alessandrini A, Barlattani M.
    Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843
    [No Abstract] [Full Text] [Related]

  • 5. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK.
    Med Welt; 1973 Sep 28; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract] [Full Text] [Related]

  • 6. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
    Spitzer S, Bach R, Schieffer H.
    Int Angiol; 1992 Sep 28; 11(3):204-10. PubMed ID: 1460355
    [Abstract] [Full Text] [Related]

  • 7. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
    Battke K, Buchwalsky R, Barmeyer J, Hoffmann G, Reindell H.
    Fortschr Med; 1978 Jul 20; 96(26-27):1381-6. PubMed ID: 669532
    [No Abstract] [Full Text] [Related]

  • 8. [A new drug in the treatment of chronic arterial diseases of the limbs].
    Schmidt C, Royer RJ, Schmitt J.
    Sem Hop; 1978 Feb 20; 54(4):210-3. PubMed ID: 208169
    [No Abstract] [Full Text] [Related]

  • 9. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
    Longo FN, Potortì F, Urbano O, Perroni GB.
    Minerva Cardioangiol; 1988 May 20; 36(5):249-52. PubMed ID: 3059229
    [No Abstract] [Full Text] [Related]

  • 10. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L, Gandolfo AM, Utz C.
    MMW Munch Med Wochenschr; 1984 Mar 02; 126(9):247-8. PubMed ID: 6425678
    [No Abstract] [Full Text] [Related]

  • 11. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W.
    Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract] [Full Text] [Related]

  • 12. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
    Horsch S, Claeys L.
    Vasa Suppl; 1992 Dec 24; 35():151-2. PubMed ID: 1481024
    [No Abstract] [Full Text] [Related]

  • 13. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
    Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G.
    Dtsch Med Wochenschr; 1987 May 29; 112(22):873-8. PubMed ID: 3556133
    [Abstract] [Full Text] [Related]

  • 14. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug 29; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 15. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994 Aug 29; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 16. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM, Lepore R.
    Clin Ter; 1990 Nov 30; 135(4):273-81. PubMed ID: 2150026
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C, Eckstein M, Hübsch-Müller C.
    Vasa; 1989 Nov 30; 18(1):40-7. PubMed ID: 2648691
    [Abstract] [Full Text] [Related]

  • 18. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
    Scheffler P, de la Hamette D, Leipnitz G.
    Vasa Suppl; 1991 Nov 30; 33():343-4. PubMed ID: 1788750
    [Abstract] [Full Text] [Related]

  • 19. [Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication].
    Horsch S, Claeys L, Diehm C, Rieger H, Cachovan M, Baitsch C.
    Vasa Suppl; 1992 Nov 30; 37():64-5. PubMed ID: 1481105
    [No Abstract] [Full Text] [Related]

  • 20. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct 30; 20(4):358-62. PubMed ID: 11038148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.